Related Experiment Video
Updated: Apr 30, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.2K
Lewy Body Dementia: The Under-Recognized but Common FOE
Cerebrum : the Dana Forum on Brain Science
|April 29, 2014
Summary
Lewy body dementia (LBD) is a common progressive dementia. LBD is often underdiagnosed due to overlapping symptoms with other neurodegenerative diseases, hindering research funding.
Area of Science:
- Neuroscience
- Neurology
- Dementia Research
Background:
- Lewy body dementia (LBD) is the second most common progressive dementia after Alzheimer's disease.
- LBD is characterized by abnormal alpha-synuclein protein aggregates (Lewy bodies) in the brain.
- Symptoms of LBD, Alzheimer's disease, and Parkinson's disease often overlap, complicating diagnosis.
Purpose of the Study:
- To highlight the prevalence and characteristics of Lewy body dementia.
- To address the diagnostic challenges associated with LBD.
- To underscore the need for increased public awareness and research funding for LBD.
Main Methods:
- This abstract summarizes existing knowledge on Lewy body dementia.
- It reviews the pathological hallmarks and clinical presentation of LBD.
- It discusses the diagnostic difficulties and research funding disparities.
Main Results:
- LBD is a significant cause of dementia, yet it remains underdiagnosed.
- Diagnostic challenges stem from symptom overlap with other neurological disorders.
- Research funding for LBD is disproportionately low compared to other cognitive disorders.
Conclusions:
- Increased awareness and research are crucial for improving LBD diagnosis and treatment.
- Addressing the underdiagnosis of LBD is essential for patient care and scientific advancement.
- Further investigation into LBD pathogenesis and effective therapies is urgently needed.
More Related Videos
08:29Symmetric Bihemispheric Postmortem Brain Cutting to Study Healthy and Pathological Brain Conditions in Humans
Published on: December 18, 2016
13.9K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.4K
Related Concept Videos
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:30Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
01:29Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:24Parkinson Disease ll: Pathophysiology
28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28
01:23Alzheimer Disease ll: Pathophysiology
35
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
35